12:00 AM
 | 
May 13, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Omeros proposes direct public offering

Omeros Corp. (NASDAQ:OMER), Seattle, Wash.
Business: Inflammation, Neurology, Ophthalmic
Date announced: 5/9/13...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >